From Pains To Gains, Human Genome Sciences Wades Through Tough Times – BIO India
This article was originally published in PharmAsia News
Executive Summary
From managing Wall Street expectations to working out smart trial designs, success at HGS is all about the processes, Thomas Watkins told BIO India attendees.